BETADEX SULFOBUTYL ETHER SODIUM

Substance profile for UNII 2PP9364507, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for BETADEX SULFOBUTYL ETHER SODIUM
Structure render from NCI/CADD chemical resolver

Substance Identity#

UNII
2PP9364507
Preferred term
BETADEX SULFOBUTYL ETHER SODIUM
Registry number
182410-00-0
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C66H112O53S6.6Na
Chemical structure for BETADEX SULFOBUTYL ETHER SODIUM
Structure render from NCI/CADD chemical resolver

Chemical And Database Identifiers#

InChIKey
VNDHXHMRJVTMTK-WZVRVNPQSA-H
SMILES
[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]3COCCCCS([O-])(=O)=O)O[C@H]4[C@H](O)[C@@H](O)[C@H](O[C@@H]4COCCCCS([O-])(=O)=O)O[C@H]5[C@H](O)[C@@H](O)[C@H](O[C@@H]5COCCCCS([O-])(=O)=O)O[C@H]6[C@H](O)[C@@H](O)[C@H](O[C@@H]6COCCCCS([O-])(=O)=O)O[C@H]7[C@H](O)[
RxCUI
1426608
PubChem
0
NCIt
C80913
INN ID
0

Open Chemistry Sources#

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SULFOBUTYLETHER .BETA.-CYCLODEXTRININACTIVE INGREDIENT2PP9364507These highlights do not include all the information needed to use GEODON safely and effectively. See full prescribing information for GEODON. GEODON (ziprasidone HCl) capsules GEODON (ziprasidone mesylate) injection for intramuscular use Initial U.S. Approval: 2001 ® ®2
SULFOBUTYLETHER .BETA.-CYCLODEXTRININACTIVE INGREDIENT2PP9364507ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]56
SULFOBUTYLETHER .BETA.-CYCLODEXTRININACTIVE INGREDIENT2PP9364507GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG]27
SULFOBUTYLETHER .BETA.-CYCLODEXTRININACTIVE INGREDIENT2PP9364507VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG]27
SULFOBUTYLETHER .BETA.-CYCLODEXTRININACTIVE INGREDIENT2PP9364507NOXAFIL (POSACONAZOLE) SUSPENSION NOXAFIL (POSACONAZOLE) TABLET, COATED NOXAFIL (POSACONAZOLE) SOLUTION [MERCK SHARP & DOHME CORP.]22
SULFOBUTYLETHER .BETA.-CYCLODEXTRININACTIVE INGREDIENT2PP9364507VORICONAZOLE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SANDOZ INC]16
SULFOBUTYLETHER .BETA.-CYCLODEXTRININACTIVE INGREDIENT2PP9364507VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG]9
SULFOBUTYLETHER .BETA.-CYCLODEXTRININACTIVE INGREDIENT2PP9364507KYPROLIS (CARFILZOMIB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ONYX PHARMACEUTICALS, INC.]8
SULFOBUTYLETHER .BETA.-CYCLODEXTRININACTIVE INGREDIENT2PP9364507VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG]7
SULFOBUTYLETHER .BETA.-CYCLODEXTRININACTIVE INGREDIENT2PP9364507NEXTERONE (AMIODARONE HYDROCHLORIDE) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION]6
SULFOBUTYLETHER .BETA.-CYCLODEXTRININACTIVE INGREDIENT2PP9364507VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG]6
sulfobutylether .beta.-cyclodextrinINACTIVE INGREDIENT2PP9364507CERENIA (MAROPITANT CITRATE) INJECTION [ZOETIS INC.]2
sulfobutylether .beta.-cyclodextrinINACTIVE INGREDIENT2PP9364507GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CARDINAL HEALTH]2
SULFOBUTYLETHER .BETA.-CYCLODEXTRININACTIVE INGREDIENT2PP9364507GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [REMEDYREPACK INC. ]1